Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non‐hypertensive Alzheimer's patients

INTRODUCTION: Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in patients with non‐hypertensive AD. Therefore, this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Hamed, Faez Saleh, Kouniaris, Stamatis, Tamimi, Iskandar, Lordkipanidzé, Marie, Madathil, Sreenath Arekunnath, Kezouh, Abbas, Karp, Igor, Nicolau, Belinda, Tamimi, Faleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377777/
https://www.ncbi.nlm.nih.gov/pubmed/34458554
http://dx.doi.org/10.1002/trc2.12184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377777/
https://www.ncbi.nlm.nih.gov/pubmed/34458554
http://dx.doi.org/10.1002/trc2.12184

Ejemplares similares